Traws Pharma, Inc. Operating Leases, Future Minimum Payments, Due in Two Years
Traws Pharma, Inc. (TRAW) had Operating Leases, Future Minimum Payments, Due in Two Years of $29.00 thousand as of 2018-12-31, per its 10-K filed 2019-04-01.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2019-04-01
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $29.00K.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $28.00K.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $28.00K.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $39.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Two Years |
|---|---|
| 2018-12-31 | $29.00K 10-K · filed 2019-04-01 |
| 2017-12-31 | $28.00K 10-K · filed 2018-03-16 |
| 2016-12-31 | $28.00K 10-K · filed 2017-03-29 |
| 2015-12-31 | $39.00K 10-K · filed 2016-03-28 |
| 2014-12-31 | $35.00K 10-K · filed 2015-03-30 |
| 2013-12-31 | $39.00K 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |